For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards

Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.NCPD information and select publications here.

Episode metadata supplied by the publisher feed · Published Mar 24, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards

0:00 1:05:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Hematologic Oncology Update?

This episode is 1 hour and 5 minutes long.

When was this Hematologic Oncology Update episode published?

This episode was published on March 24, 2025.

Can I download this Hematologic Oncology Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!